Approval · Notice of Compliance 12345 · 2011
REACTINE LIQUID GELS: Notice of Compliance 12345
Issued May 12, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12345
- Date
- May 12, 2011
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Histamine H1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE LIQUID GELS | 02368064 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per CAP